Film-forming formulations represent a novel form of sustained release dermatic products.用于皮肤液化或半固化编程通过皮肤挥发溶剂蒸发,配方内含聚合物组成固膜各种胶片配方测试水阻抗并作比较 [.]
Der Betrag Film-forming formulations represent a novel form of sustained release dermatic products.用于皮肤液化或半固化编程通过皮肤挥发溶剂蒸发,配方内含聚合物组成固膜各种胶片配方测试水阻和压强并比对传统半固化配方渗透渗透研究显示半转基因治疗系统有潜在实用性可替代补丁系统以切题方式管理各种药物并持续发布特征。
Polymers for use in film-forming formulations
Polymer | Properties |
---|---|
Carbopol (polyacrylat) | water-soluble, pH sensitive |
Chitosan (Poly-D-Glucosamin) | water-soluble at pH < 7 |
Crosslinked polymer layer XPL | adhesive, elastic |
Dermacryl 79 (Carboxylates Acrylpolymer) | water-insoluble |
Ethylcellulose | non-toxic, not irritating, anti-allergic |
Eudragit NE (ethylacrylate methylmethacrylate copolymer) | water-insoluble, transparent, elastic, adhesive |
Eudragit RL-100 (polymethacrylate polymere) | water-insoluble, transparent, elastic, adhesive |
Eudragit RS-100 (polymethacrylate polymere) | water-insoluble, transparent, elastic, adhesive |
Eudragit L30D-55 (methacrylate-ethylacrylate-copolymer) | water dispersible at pH 2–3 |
Hydroxypropyl-beta-cyclodextrin | water-insoluble, increases bioavailability |
Hydroxypropylmethylcellulose (HPMC) | water-soluble, non-ionic |
KIucel (Hydroxypropyl cellulose) | water-soluble, non-ionic |
Macrogol | water-soluble |
Methyl cellulose | water-soluble |
Poloxamer (polyethylenepolypropylene glycol) | thermoreversible |
Plastoid (Butyl methacrylate-methylmethacrylate copolymer) | water-insoluble |
Polydimethylsiloxane (PDMS) | water-insoluble, non-toxic |
Polyvinyl alcohol (PVA) | water-soluble, adhesive, non-toxic |
Polyvinyl pyrrolidine (PVP) | water-soluble, adhesive, increase bioavailability |
Quaternary polymethacrylat (QPM) | water-insoluble |
Sepineo P600 (acrylamide/sodium acryloldimethyltaurate) | water-insoluble |
Silicone | water-soluble, non-occlusive |
The oral route is the most common form of drug administration, being a safe and convenient, particularly for solid oral dosage forms.当前大规模制造技术大都产生固定剂量单元并允许有限选择用量强在某些情况下,需要用药强度个性化化,包括髓治法理学
The oral route is the most common form of drug administration, being a safe and convenient, particularly for solid oral dosage forms.当前大规模制造技术大都产生固定剂量单元并允许有限选择用量强在某些情况下,需要用药强度个性化化,包括髓治疗指数药或伴生药药药-药性/药效药-药性交互作用、酶或运输器药性变异性,以及特殊人群,包括老年人、儿童和肾功能缺陷/肝功能缺陷患者a类='btnbn-defaultbn-md'hrefs.com/wp-content/uploads/2021/06/this-print-a-aproach-to-Dose个性化可以通过复合或使用其他管理路径实现(例如侧接式),但这些路径缺少与标准制造相同的质量控制水平,不便/可接受性差不等。自动制造个性化固口化强力可解决这一需求开发三维打印自动逐层生成自定义平板三维打印片片子除单点使用外,还有可能用于早期临床试验期间的剂量升级、制片点药短期和制作复杂多药片片件并配有个人化配方图解特别是阻塞沉积建模(FDM),它涉及通过窄热喷嘴并随后沉积准备固态物体而分解热塑丝,似乎对临床现场生产有帮助,因为制造过程没有松散粉末,后处理可以避免。FDM应用需要FDM处理线程由热熔扩展制造。
IR是口服量表最常用发布剖面图,并同时产生来自通过热熔流程制造三维打印片片的固有特性的重大挑战 工作旨在为从FDM-和直接粉打印中产生的独特值建议创建选项,这些方面与标准制造过程基本不同(即分散化制作和定制平板结构)。临界质量属性(CQAs)集成为3D打印片片片的成功标准,包括内容一致性提供剂量精度(相对标准一致性数据偏差)、权重一致性(以确保内容一致性)、分解剖面貌(目标快速释放)和物理化学稳定性此外,还考虑了开发三维打印剂量表的可接受外观和大小。
关键目标之一是开发一个工业化配方工具箱,适合不同的API开发可缩热熔挤出配方并装有多种药量首项研究探索选定前接收者组合实现快速或极快从FDM打印片状带水益模型复合所选水溶聚合物和水分分解/处理辅助工具对FDM兼容性的影响,并结合填充密度对配方质量属性的影响(即重量和内容一致性、分解率)进行了研究。Hypray-Cellose SSL选择为水益聚合物和咖啡因,药载量5-20%热稳定模型药Poly-Serveridone-vilenegletate聚合物(在第三次研究中开发出易溶性模型复合立即释放FDM表,并使用非损性精确形态分析检测出分解关键结构参数基本methacrylate共聚物( 虽然FDM打印可能有利于临床现场制造,因为打印过程没有粉末或溶剂参与,但一大挑战是如何实现丝状所需机械性能允许FDM处理第四次研究探索直接粉色3D打印平板片,省略了简化引信沉积建模的丝片步骤直接三维打印时,粉状混合装入像盒头并成功打印出蜂窝设计跨步DPP内装孔度高表面积证明概念制作快速释放用量表水溶性HPCSSL选择矩阵前和咖啡因模拟药PEG4000增塑原型和KollidonQVA64快速分解聚合物对DPP可处理性和解析率的影响得到了调查3D打印低密度(30%)显示快速分解与配方无关,而高填密度(80%)则需要PEG4000和KollidonVA64组合实现快速释放所得平板显示药含量百分比完全一致,但有可变权重咖啡因以晶状状态和稳定多态形式出现直接粉末打印可行性即时释放用量表制作这种方法可创造避免热熔溢出的机会,允许三维打印独立于线性机械特性并有可能通过减热延长产品架存存存存期。
开发表板时对成人和儿童的尺寸都满足一致性内容需求,以提供精度剂量(相对标准一致性数据偏差)、权重一致性、分解目标(快速释放)和物理化学稳定性运算学研究表明,未来开发IR3D打印剂量表,除适当聚合矩阵选择外,还可以减少闭口孔量,增加开孔量,优化形状/大小和分解之间的平衡水益聚合矩阵与CAD设计相结合,通过FDM或DPP制造,对未来3D打印药产品开发大有希望然而,仍应克服的挑战包括直径整齐化丝状物、精度和可复制沉积质量、设计密度和实际密度差异、可预测最终形态学和丝状机械性能In addition, there might be a need in a real-time monitoring of flow and viscosity of the molten mass during the 3D-printing process.
Download the full dissertation as a PDF here
Author: Marina Fanous, Basel University.
Der Beitrag Three-dimensional printing of tablets – a potential approach to on-clinical-site extemporaneous formulation and personalized medicine erschien zuerst auf Pharma Excipients.
Photo-aging is caused mainly by sun radiations, which consist mainly of the ultraviolet radiation (UVA and UVB).Ascobic酸(AA)在整形场被广泛使用,作为反纹理、抗敏化和抗氧化物剂,然而,它的整形应用有限,原因是它渗透皮肤差,快速氧化作用,以及ss
BeitragPhoto-aging is caused mainly by sun radiations, which consist mainly of the ultraviolet radiation (UVA and UVB).cobic酸(AA)在整形场被广泛使用,作为一种反纹理、抗胃药剂和抗氧化物药剂,然而,其整形应用有限,原因是皮肤渗透率低、快速氧化化和配方不稳定。
本项研究的目的是用纳米模化策略交付AA并稳定化80 mg/mlA入水内油(O/W)纳米并定性为小滴大小、zeta潜力、热动稳定性和形态学hrefs/www.pharmaexsubjects.com/?sssss=sort&ids#sqflictssssAA纳米反射平均小滴大小14.4+1.9Nm,zeta潜力接近零。
a纳米反射物理稳定显示离散测试和加热/冷凝测试后无相位分离或扰动性遍历Strat-MQ+mbrane的AA累积量为602.2++57.9mg/cmsup2 ex渗透剖面图显示AA受控释放剖面图24H释放配对Higuchi模型相关系数为0.995Nanoemulsion-based patches could serve a potential system for the dermal delivery of unstable hydrophilic compound.Article information: (2021) Nanoemulsion-based patch for the dermal delivery of ascorbic acid, Journal of Dispersion Science and Technology, DOI:10.1080/01932691.2021.1880924
Der Beitrag Nanoemulsion-based patch for the dermal delivery of ascorbic acid erschien zuerst auf Pharma Excipients.
INTRODUCTION Plasticiser play a decisive role in the application of functional films, especially, if an aqueous dispersion containing a water insoluble polymer is used.水分持续释放薄膜组成聚合物PVAC, 分片延长和最小成模温度都强烈依赖[.]
/derBeitragPlasticiser play a decisive role in the application of functional films, especially, if an aqueous dispersion containing a water insoluble polymer is used.水解持续释放薄膜组成聚合PVAC, 分拆延长和最小薄膜形成温度都强烈依赖
Materials:
Poly(vinyl acetate) (Kollicoat® SR 30 D, BASF SE, Germany) was used in combination with the following plasticisers:
Formulations
The isolated films were prepared with a plasticiser content of 10% (m/m) each, calculated on the polymer content of the dispersion.为确保PVAC分布和整合均匀性,混合作用至少2小时。
单片使用装有300微米刀的胶片放映器(CoatmasterErichsen测试设备)制作胶片投影器允许各种温度擦干胶片。
确定机械性能时使用纹理分析器(TA-XT2iHR,稳定微系统)。测试条件受气候控制23摄氏度和54%r.h[2]